ICU Risk Stratification Models Feasible for Use in Sub-Saharan Africa Show Poor Discrimination in Malawi: A Prospective Cohort Study.
Journal
World journal of surgery
ISSN: 1432-2323
Titre abrégé: World J Surg
Pays: United States
ID NLM: 7704052
Informations de publication
Date de publication:
10 2019
10 2019
Historique:
pubmed:
18
7
2019
medline:
29
1
2020
entrez:
18
7
2019
Statut:
ppublish
Résumé
Critical illness disproportionately affects people in low-income countries (LICs). Efforts to improve critical care in LICs must account for differences in demographics and infrastructure compared to high-income settings. Part of this effort includes the development and validation of intensive care unit (ICU) risk stratification models feasible for use in LICs. The purpose of this study was to validate and compare the performance of ICU mortality models developed for use in sub-Saharan Africa. This was a prospective, observational cohort study of ICU patients in a referral hospital in Malawi. Models were selected for comparison based on a Medline search for studies which developed ICU mortality models based on cohorts in sub-Saharan Africa. Model discrimination was evaluated using the area under the curve with 95% confidence intervals (CI). During the study, 499 patients were admitted to the study ICU, and after exclusions, there were 319 patients. The cohort was 62% female, with the mean age 31 years (IQR: 23-41), and 74% had surgery preceding ICU admission. Discrimination for hospital mortality ranged from 0.54 (95% CI 0.48, 0.60) for the Universal Vital Assessment (UVA) to 0.72 (95% CI 0.66, 0.78) for the Malawi Intensive care Mortality Evaluation (MIME). After tenfold cross-validation, these results were unchanged. The MIME outperformed other models in this prospective study. Most ICU models developed for LICs had poor to modest discrimination for hospital mortality. Future research may contribute to a better risk stratification model for LICs by refining and enhancing the MIME.
Sections du résumé
BACKGROUND
Critical illness disproportionately affects people in low-income countries (LICs). Efforts to improve critical care in LICs must account for differences in demographics and infrastructure compared to high-income settings. Part of this effort includes the development and validation of intensive care unit (ICU) risk stratification models feasible for use in LICs. The purpose of this study was to validate and compare the performance of ICU mortality models developed for use in sub-Saharan Africa.
MATERIALS AND METHODS
This was a prospective, observational cohort study of ICU patients in a referral hospital in Malawi. Models were selected for comparison based on a Medline search for studies which developed ICU mortality models based on cohorts in sub-Saharan Africa. Model discrimination was evaluated using the area under the curve with 95% confidence intervals (CI).
RESULTS
During the study, 499 patients were admitted to the study ICU, and after exclusions, there were 319 patients. The cohort was 62% female, with the mean age 31 years (IQR: 23-41), and 74% had surgery preceding ICU admission. Discrimination for hospital mortality ranged from 0.54 (95% CI 0.48, 0.60) for the Universal Vital Assessment (UVA) to 0.72 (95% CI 0.66, 0.78) for the Malawi Intensive care Mortality Evaluation (MIME). After tenfold cross-validation, these results were unchanged.
CONCLUSIONS
The MIME outperformed other models in this prospective study. Most ICU models developed for LICs had poor to modest discrimination for hospital mortality. Future research may contribute to a better risk stratification model for LICs by refining and enhancing the MIME.
Identifiants
pubmed: 31312950
doi: 10.1007/s00268-019-05078-9
pii: 10.1007/s00268-019-05078-9
doi:
Types de publication
Journal Article
Observational Study
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
2357-2364Subventions
Organisme : FIC NIH HHS
ID : R25 TW009340
Pays : United States
Références
Crit Care Med. 2015 Aug;43(8):1587-94
pubmed: 25867907
PLoS One. 2016 May 19;11(5):e0155858
pubmed: 27196252
Trop Med Int Health. 2009 Jan;14(1):29-35
pubmed: 19121148
Int J Equity Health. 2016 Oct 18;15(1):173
pubmed: 27756374
Chest. 2008 Jun;133(6):1319-1327
pubmed: 18403657
Crit Care Med. 1985 Oct;13(10):818-29
pubmed: 3928249
Crit Care. 2018 Jan 26;22(1):18
pubmed: 29373996
JAMA. 1993 Nov 24;270(20):2478-86
pubmed: 8230626
J Intensive Care Med. 2016 Aug;31(7):485-9
pubmed: 26188013
Int J Surg. 2017 Oct;46:198-202
pubmed: 28890409
Int Health. 2015 Jan;7(1):60-6
pubmed: 25135818
Chest. 2010 Jul;138(1):68-75
pubmed: 20418364
Infection. 2017 Dec;45(6):893-896
pubmed: 28786004
Chest. 2012 Oct;142(4):982-987
pubmed: 22459780
Crit Care. 2016 Dec 1;20(1):390
pubmed: 27903270
BMJ Glob Health. 2017 Jul 28;2(2):e000344
pubmed: 29082001
PLoS One. 2016 Mar 17;11(3):e0151408
pubmed: 26986466
Ann Am Thorac Soc. 2013 Oct;10(5):509-13
pubmed: 24161054
J Crit Care. 2018 Feb;43:81-87
pubmed: 28854400
Lancet Respir Med. 2014 May;2(5):380-6
pubmed: 24740011
JAMA. 1993 Dec 22-29;270(24):2957-63
pubmed: 8254858
Int J Surg. 2018 Dec;60:60-66
pubmed: 30395945
JAMA. 2016 Feb 23;315(8):762-74
pubmed: 26903335
Biometrics. 1988 Sep;44(3):837-45
pubmed: 3203132
Chest. 2010 Jun;137(6):1289-96
pubmed: 20173054
Iran J Med Sci. 2016 May;41(3):171-9
pubmed: 27217600
J Intensive Care Med. 2018 Dec 4;:885066618815804
pubmed: 30514154